HVTN 104

A Phase 1 Clinical Trial to Evaluate the Safety and Drug Levels of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01) Administered in Multiple Doses Intravenously and Subcutaneously in Different Dosing Schedules to Healthy, HIV-Uninfected Adults

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID) August 01, 2014
VRC-HIVMAB060-00-AB VRC01 Antibody
VRC-HIVMAB060-00-AB Passive Immunization
USA 88